Skip to main content
    S

    Sanara Medtech Inc (SMTI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $32.73
    -0.03 (-0.09%)

    Market Cap: $300.83M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Sanara Medtech Inc (SMTI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sanara Medtech (SMTI) has a market cap of $300.83M and an enterprise value of $330.76M. Its return on invested capital of 16.87% compares with a 6.74% median across 7 similar companies.

    Total Valuation

    Enterprise value is 9.95% above the market cap, as debt exceeds cash.

    Market Cap$300.83M
    Enterprise Value$330.76M
    Latest price (Nov 17, 2026)$32.73

    Key Dates

    The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 22, 2027 (expected)
    Last Earnings DateNov 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.39% in the quarter ended Sep 30, 2026 and grew 1.55% a year over 2 years.

    Shares Outstanding8.78M
    Shares Change (YoY)+1.58%
    Shares Change (QoQ)+1.39%
    Share Count Growth (2Y CAGR)+1.55%

    Valuation Ratios

    Sales and book value multiples are 2.6x and 37.5x. Its year-end P/S ranged from 1.8x to 18.6x from 2019 to 2025.

    Forward P/E156.5x
    P/S Ratio2.6x
    Forward P/S2.6x
    P/B Ratio37.5x
    P/OCF Ratio40.5x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 22.0x EBITDA.

    EV / Sales3.0x
    EV / EBITDA22.0x
    EV / EBIT28.5x

    Price Statistics

    The stock is up 51.95% over 52 weeks and trades 3.42% below its 50-day average.

    Beta (1Y)0.49
    52-Week Change+51.95%
    1-Month Change-1.24%
    3-Month Change-4.52%
    6-Month Change+44.06%
    5-Year Change-5.93%
    10-Year Change+557.92%
    Total Return (1Y)+51.95%
    Total Return (3Y CAGR)-0.36%
    Total Return (5Y CAGR)+1.07%
    Return vs SPY (1Y)+45.04%
    Max Drawdown (1Y)-36.94%
    Max Drawdown (3Y)-60.72%
    Sharpe Ratio (1Y)0.91
    Correlation with SPY (1Y)0.14
    50-Day Average$33.89
    200-Day Average$26.09
    52-Week Range$16.05 to $35.52
    RSI (14 Days)48.5
    Average Volume (20 Days)64.55K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.24x current liabilities, and total debt is 6.10x shareholder equity.

    Current Ratio2.24x
    Quick Ratio2.03x
    Debt / Equity6.10x
    Debt / EBITDA3.24x
    Interest Coverage1.60x

    Returns and Efficiency

    Return on invested capital is 16.87% over the last 12 months, against a 5-year average of -4.79%.

    Return on Equity (ROE)-39.34%
    Return on Assets (ROA)-4.17%
    Return on Invested Capital (ROIC)16.87%
    Return on Capital Employed (ROCE)20.76%
    ROA (5Y Average)-20.80%
    ROIC (5Y Average)-4.79%
    Asset Turnover1.56x
    Inventory Turnover2.33x
    Receivables Turnover7.93x
    Cash Conversion Cycle50 days

    Scores

    SMTI has an Altman Z-Score of 3.61, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score3.61
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $111.88M over the last 12 months is up 9.82% from the 12 months before.

    Revenue$111.88M
    Revenue Growth (YoY)+9.82%
    Gross Profit$104.00M
    Operating Income$11.64M
    Pretax Income$3.03M
    Net Income-$3.02M
    EBITDA$14.40M
    EBIT$11.62M
    Reported EPS (TTM)$0.02

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 10.62% of the $72.24M in total assets.

    Cash and Equivalents$16.79M
    Total Debt$46.72M
    Net Debt$29.94M
    Net Debt Per Share$3.41
    Working Capital$20.12M
    Shareholder Equity$7.67M
    Book Value Per Share$0.87
    Tangible Book Value-$12.63M
    Total Assets$72.24M
    Total Liabilities$64.57M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow$7.42M
    FCF Per Share$0.79
    Depreciation and Amortization$2.78M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 10.40%, against a 5-year average of -11.16%.

    Gross Margin92.95%
    Operating Margin10.40%
    Pretax Margin2.71%
    Net Margin-2.70%
    EBITDA Margin12.87%
    EBIT Margin10.38%
    Gross Margin (5Y Average)89.56%
    Operating Margin (5Y Average)-11.16%
    Net Margin (5Y Average)-21.09%

    Growth

    Revenue grew 31.03% a year over 3 years.

    Revenue Growth (3Y CAGR)+31.03%
    Revenue Growth (5Y CAGR)+45.92%
    Book Value Per Share Growth (2Y CAGR)-63.79%

    Revenue and profit by year

    Stock Splits

    The last split was a 1-for-100 reverse split on May 10, 2019.

    Last Split DateMay 10, 2019
    Split TypeReverse split
    Split Ratio1:100

    Peer Position

    Against 12 similar companies, SMTI has the 9th highest P/S.

    P/S Ratio2.6x vs 3.0x median
    ROIC16.87% vs 6.74% median
    Revenue Growth (Trailing 4 Quarters, YoY)+9.82% vs +8.20% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 13.65% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+13.65%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SMTI

    What is SMTI's market cap?

    Sanara Medtech has a market cap of $300.83M. Its enterprise value, which adds debt and subtracts cash, is $330.76M.

    How many shares of SMTI are outstanding?

    Sanara Medtech has 8.78M shares outstanding. The count is up 1.58% from a year earlier.

    Does SMTI pay a dividend?

    No. Sanara Medtech does not pay a dividend.

    How much debt does SMTI have?

    Sanara Medtech has $46.72M of total debt and $16.79M of cash and equivalents, a net debt position of $29.94M.